- Home
- JRS vs BLDE Comparison
JRS vs BLDE Comparison
Compare JRS & BLDE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JRS
- BLDE
- Stock Information
- Founded
- JRS 2001
- BLDE 2014
- Country
- JRS United States
- BLDE United States
- Employees
- JRS N/A
- BLDE N/A
- Industry
- JRS Finance/Investors Services
- BLDE Aerospace
- Sector
- JRS Finance
- BLDE Consumer Discretionary
- Exchange
- JRS Nasdaq
- BLDE Nasdaq
- Market Cap
- JRS 267.5M
- BLDE 276.7M
- IPO Year
- JRS N/A
- BLDE N/A
- Fundamental
- Price
- JRS $8.53
- BLDE $4.11
- Analyst Decision
- JRS
- BLDE Buy
- Analyst Count
- JRS 0
- BLDE 1
- Target Price
- JRS N/A
- BLDE $6.00
- AVG Volume (30 Days)
- JRS 86.6K
- BLDE 1.0M
- Earning Date
- JRS 01-01-0001
- BLDE 03-11-2025
- Dividend Yield
- JRS 8.87%
- BLDE N/A
- EPS Growth
- JRS N/A
- BLDE N/A
- EPS
- JRS N/A
- BLDE N/A
- Revenue
- JRS N/A
- BLDE $241,814,000.00
- Revenue This Year
- JRS N/A
- BLDE $11.34
- Revenue Next Year
- JRS N/A
- BLDE $5.73
- P/E Ratio
- JRS N/A
- BLDE N/A
- Revenue Growth
- JRS N/A
- BLDE 12.04
- 52 Week Low
- JRS $5.95
- BLDE $2.45
- 52 Week High
- JRS $8.00
- BLDE $5.17
- Technical
- Relative Strength Index (RSI)
- JRS 46.97
- BLDE 49.59
- Support Level
- JRS $8.14
- BLDE $3.43
- Resistance Level
- JRS $8.70
- BLDE $5.14
- Average True Range (ATR)
- JRS 0.19
- BLDE 0.35
- MACD
- JRS 0.03
- BLDE -0.05
- Stochastic Oscillator
- JRS 67.24
- BLDE 39.77
About JRS Nuveen Real Estate Income Fund of Beneficial Interest
Nuveen Real Estate Income Fund is a diversified closed-end investment company. The Fund invests primarily in income-producing common stocks, preferred stocks, convertible preferred stocks, and debt securities issued by real estate companies. At least 75% of the Fund's managed assets will be in securities rated investment grade.
About BLDE Blade Air Mobility Inc.
Blade Air Mobility Inc is a technology-powered air mobility platform that provides air transportation and logistics for hospitals and is a transporter of human organs for transplant, and for passengers, with helicopter and fixed-wing services predominantly in the Northeast United States, Southern Europe and Western Canada. The company's operating segments are; Passenger, and Medical. Majority of the revenue for the company is generated from its Medical segment which predominantly consists of transportation of human organs for transplant and the medical teams supporting these services. It also offers additional services including donor logistics coordination and support in evaluating potential donor organs. A substantial portion of the company's revenue is generated from the United States.